The Amifampridine Phosphate 
Expanded Access Program (EAP)

CALL TOLL FREE 1-844-347-3277

Contact us about the Amifampridine Phosphate Expanded Access Program (EAP)

If you would like more information about or are interested in participating in the amifampridine phosphate EAP, please fill out your information below.  We will be in touch with you shortly.

The FDA has not yet approved amifampridine phosphate for the treatment of either LEMS or CMS.

FOR MORE INFORMATION ABOUT CATALYST PHARMACEUTICALS